<DOC>
	<DOCNO>NCT02064413</DOCNO>
	<brief_summary>To evaluate safety successful placement rate Essure Model ESS310 device factor may influence successful placement rate device .</brief_summary>
	<brief_title>Essure ( Model ESS310 ) Placement Rate Study</brief_title>
	<detailed_description />
	<criteria>Females age range 21 44 year Subjects seek permanent contraception Subjects body weight within range 90300 pound ( 40 136 kilogram ) Subjects medical history indicate bilateral viable patent fallopian tubes Subjects able willing comply protocol require followup visit Subjects fulfil local requirement counsel consent contraception sterilization , include require wait period Subjects provide write informed consent prior enrolment Subjects sufficient mental capacity understand inform consent form ( ICF ) , comply protocol requirement , provide clinically relevant reliable feedback regard experience implant subsequent wear device Subjects agree anonymized personal data make available study Sponsor requisite regional international regulatory body Subjects suspect confirm pregnant Subjects postpartum undergone pregnancy termination â‰¤6 week schedule insert placement Subjects know proximal tubal occlusion either fallopian tube Subjects undergone fallopian tube sterilization procedure Subjects total partial salpingectomy Subjects diagnose tubal , endometrial , myometrial pathology may prevent fallopian tube ostia access Subjects diagnose unicornuate uterus Subjects diagnose active currently treat upper low pelvic infection Subjects gynecologic malignancy Subjects currently take corticosteroid Subjects know allergy contrast medium available use HSG ( Hysterosalpingogram ) Subjects schedule undergo concomitant intrauterine procedure time insert placement ( e.g. , endometrial ablation , fibroid resection hysteroscopy , endometrial polypectomy ) . Intrauterine device removal consider concomitant procedure . Subjects general health condition systemic disease may represent , opinion physician , potential increase risk associate device use pregnancy Subjects close affiliation investigational site , e.g . closely related affiliated investigator ( dependent , employee student investigational site , sponsor 's staff )</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Birth control</keyword>
</DOC>